Literature DB >> 31132771

Transcultural Adaptation and Validation of the Voice Handicap Index-10 into the Serbian Language.

Jadranka Maksimovic1, Milan Vukasinovic2, Hristina Vlajinac1, Ana Jotic2,3, Vojko Djukic2,3, Jelena Marinkovic4, Sanja Krejovic-Trivic2,3, Jovica Milovanovic5,6.   

Abstract

BACKGROUND: The Voice Handicap Index-10 (VHI-10) is used in clinics because of its validity and ease of use by patients.
OBJECTIVES: The aim of this paper was to evaluate the internal consistency, reliability, and clinical validity of the Serbian version of the VHI-10.
METHOD: In this cross-sectional study, we translated the original English version of the VHI-10 into Serbian, after which it was back-translated into English. The Serbian version of the VHI-10 was completed by 161 patients with voice disorders, divided into 4 groups according disease etiology (structural, neurological, functional, and inflammatory) and 73 healthy control subjects.
RESULTS: The VHI-10 internal consistency was 0.88. Spearman's rank correlation coefficient for VHI-10 test-retest reliability was ρ = 0.991 (p< 0.001). Patients with voice disorders had higher median total VHI-10 scores compared with controls (p< 0.001). The patients' Grade, Instability, Roughness, Breathiness, Asthenia, and Strain (GIRBAS) scale scores were significantly correlated with the VHI-10 test scores (ρ = 0,682, p < 0.001) and VHI-10 retest scores (ρ = 0.716, p < 0.001).
CONCLUSION: The Serbian version of the VHI-10 had good validity and reliability and can be used by Serbian patients with voice disorders.
© 2019 S. Karger AG, Basel.

Entities:  

Keywords:  Quality of life; Serbian version; Validity; Voice Handicap Index; Voice disorders

Mesh:

Year:  2019        PMID: 31132771     DOI: 10.1159/000499927

Source DB:  PubMed          Journal:  Folia Phoniatr Logop        ISSN: 1021-7762            Impact factor:   0.849


  1 in total

1.  Validity, internal consistency, and test-retest reliability of the Montenegrin 10-item Voice Handicap Index.

Authors:  Elvir Zvrko; Muhedin Kadić
Journal:  Arh Hig Rada Toksikol       Date:  2022-07-07       Impact factor: 2.078

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.